Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands

被引:60
作者
Chelopo, Madichaba P. [1 ]
Pawar, Sachin A. [1 ]
Sokhela, Mxolisi K. [1 ]
Govender, Thavendran [1 ]
Kruger, Hendrik G. [1 ]
Maguire, Glenn E. M. [1 ]
机构
[1] Univ KwaZulu Natal, Sch Hlth Sci, Catalysis & Peptide Res Unit, ZA-4000 Durban, KwaZulu Natal, South Africa
基金
新加坡国家研究基金会;
关键词
Anticancer; Tetrahydroisoquinoline; Ruthenium; CYTOTOXIC ACTIVITY; ANTITUMOR-ACTIVITY; BREAST-CANCER; CELL-LINES; TETRAHYDROISOQUINOLINES; DERIVATIVES; CHEMISTRY; MEDICINE; BIOLOGY; ACIDS;
D O I
10.1016/j.ejmech.2013.05.048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ruthenium complexes offer potential reduced toxicity compared to current platinum anticancer drugs. 1,2,3,4-tetrahydrisoquinoline amino alcohol ligands were synthesised, characterised and coordinated to an organometallic Ru(II) centre. These complexes were evaluated for activity against the cancer cell lines MCF-7, A549 and MDA-MB-231 as well as for toxicity in the normal cell line MDBK. They were observed to be moderately active against only the MCF-7 cells with the best IC50 value of 34 mu M for the cis-diastereomeric complex C4. They also displayed excellent selectivity by being relatively inactive against the normal MDBK cell line with SI values ranging from 2.3 to 7.4. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 49 条
[11]   Synthesis of isoquinolines and tetrahydroisoquinolines as potential antitumour agents [J].
Capilla, AS ;
Romero, M ;
Pujol, MD ;
Caignard, DH ;
Renard, P .
TETRAHEDRON, 2001, 57 (39) :8297-8303
[12]   Synthesis and Screening of C1-Substituted Tetrahydroisoquinoline Derivatives for Asymmetric Transfer Hydrogenation Reactions [J].
Chakka, Sai Kumar ;
Andersson, Pher G. ;
Maguire, Glenn E. M. ;
Kruger, Hendrik G. ;
Govender, Thavendran .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2010, 2010 (05) :972-980
[13]   Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: Novel recognition mechanisms [J].
Chen, HM ;
Parkinson, JA ;
Morris, RE ;
Sadler, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (01) :173-186
[14]   Catalytic organometallic anticancer complexes [J].
Dougan, Sarah J. ;
Habtemariam, Abraha ;
McHale, Sarah E. ;
Parsons, Simon ;
Sadler, Peter J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (33) :11628-11633
[15]   Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes [J].
Fernández, R ;
Melchart, M ;
Habtemariam, A ;
Parsons, S ;
Sadler, PJ .
CHEMISTRY-A EUROPEAN JOURNAL, 2004, 10 (20) :5173-5179
[16]   RISING INCIDENCE OF BREAST-CANCER - RELATIONSHIP TO STAGE AND RECEPTOR STATUS [J].
GLASS, AG ;
HOOVER, RN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (08) :693-696
[17]   NMR chemical shifts of common laboratory solvents as trace impurities [J].
Gottlieb, HE ;
Kotlyar, V ;
Nudelman, A .
JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (21) :7512-7515
[18]   Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds [J].
Govender, Preshendren ;
Renfrew, Anna K. ;
Clavel, Catherine M. ;
Dyson, Paul J. ;
Therrien, Bruno ;
Smith, Gregory S. .
DALTON TRANSACTIONS, 2011, 40 (05) :1158-1167
[19]   SYNTHESIS AND EVALUATION OF 3-SUBSTITUTED ANALOGS OF 1,2,3,4-TETRAHYDROISOQUINOLINE AS INHIBITORS OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE [J].
GRUNEWALD, GL ;
SALL, DJ ;
MONN, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (04) :824-830
[20]   Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands [J].
Habtemariam, Abraha ;
Melchart, Michael ;
Fernandez, Rafael ;
Parsons, Simon ;
Oswald, Iain D. H. ;
Parkin, Andrew ;
Fabbiani, Francesca P. A. ;
Davidson, James E. ;
Dawson, Alice ;
Aird, Rhona E. ;
Jodrell, Duncan I. ;
Sadler, Peter J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6858-6868